tirzepatide cardiovascular outcomes study trial results july 2025 Achieving BMI <25 kg/m2 was associated with reduced Tirzepatide and Cardiovascular Outcomes: A

It is the most frequently reported side effect of tirzepatide, affecting roughly 15 to 30 percent of patients depending on the dose

Well, it's an unfortunate name, but she's

1, reaction 10) obtained from THF (Fig

The most commonly reported side effects in clinical trials include: Nausea Vomiting Diarrhea Constipation Most of these symptoms were mild to moderate and tended to improve over time as the body adjusted to the medication, especially when doses were increased gradually

Many people at stable maintenance doses report minimal or no side effects after the initial adjustment period

Heres what you can expect from working with Paloma Health: Comprehensive thyroid care , including convenient home thyroid testing, symptom tracking, and personalized treatment plans Metabolic health assessments to determine GLP-1 suitability and guide next steps Integrated, whole-body care that aligns your thyroid treatment with your weight loss and blood sugar goals Ongoing support and education , so you never feel like youre navigating your health alone Individualized care, consistent monitoring, and a deep understanding of how thyroid and metabolic systems interact are the foundation of our approach